8-K
filed May 20, 2026, 4:59 PM ET
ticker AMGN
CIK 0000318154
other material
confidence high
sentiment neutral
materiality 0.15
Amgen annual meeting elects all 12 directors; shareholder independent-chair proposal rejected
AMGEN INC
- All 12 director nominees elected; Robert Bradway received 390M votes for, 20.5M against.
- Advisory vote to approve executive compensation passed with 399M for, 12M against.
- Ernst & Young ratified as auditor for FY2026 with 447M for, 28M against.
- Stockholder proposal to require independent board chairman failed: 72.9M for, 338.5M against.
- Broker non-votes of 63.7M on all items except auditor ratification.
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
AMGEN INC shareholders approved Election of Directors at the 2026-05-19 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2026-05-19
Exact text from the filing
Item 1 - Election of Directors Each of the following 12 nominees for director were elected to serve a one-year term expiring at the Company’s 2027 annual meeting of stockholders and until his or her successor is elected and qualified, or until his or her earlier retirement, resignation, disqualification, removal or death.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
AMGEN INC shareholders approved Advisory Vote to Approve Our Executive Compensation at the 2026-05-19 meeting.
- Proposal
- say on pay
- Outcome
- passed
- Meeting
- 2026-05-19
Exact text from the filing
Item 2 - Advisor y Vote to A pprove Our Executive Compensation The advisory vote to approve our executive compensation was approved.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
AMGEN INC shareholders approved Ratification of Selection of Independent Registered Public Accountants at the 2026-05-19 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2026-05-19
Exact text from the filing
Item 3 - Ratification of Selection of Inde pendent Re gistered Public Accountants Ernst & Young LLP was ratified as the Company’s independent registered public accountants for the fiscal year ending December 31, 2026.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
AMGEN INC shareholders rejected Stockholder Proposal to Require an Independent Board Chairman at the 2026-05-19 meeting.
- Outcome
- failed
- Meeting
- 2026-05-19
Exact text from the filing
Item 4 - Stockholder Proposal to Require an Independent Board Chairman The stockholder proposal to require an independent board chairman was not approved.
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.